Golimumab (CNTO-148) is a potent humanized anti-TNFalpha IgG1kappa monoclonal antibody.Golimumab has anti-inflammatory and anticancer activity, inhibits the production of IL-6 and IL-1beta, and induces apoptosis.Golimumab can be used to prevent inflammation and des
CAS Number:
[476181-74-5]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted